Not long ago, basketball fans received shocking news: Victor Wembanyama, the center for the San Antonio Spurs, will miss the rest of the season due to deep vein thrombosis in his right shoulder. Despite the seriousness of the diagnosis, medical experts and team representatives are confident that this is a temporary pause, not the end of the star player’s career.
What Happened to Wembanyama?
Deep vein thrombosis is a condition where a blood clot (thrombus) forms in the veins. In Wembanyama’s case, the issue arose in his right shoulder. It can cause swelling, pain, or progress almost symptom-free. The most dangerous scenario occurs when the clot breaks loose and travels to the lungs, causing pulmonary embolism. Fortunately, the clot was detected, and treatment has already begun.
According to interim head coach of the Spurs, Mitch Johnson, there is no threat to the end of his career. “Medical experts have confirmed that Wembanyama will not play this season, but his long-term health is not at risk. We are confident he will be ready for the next season,” Johnson stated.
How Is Thrombosis Treated in Athletes?
Treatment typically involves taking blood-thinning medications (anticoagulants), which must be taken for about six months. During this period, athletes are prohibited from participating in contact sports due to the high risk of injury. Sometimes surgical intervention may be required if conservative treatment fails. However, it seems that such a necessity does not apply to Wembanyama.
Examples from other NBA players show that recovery is possible. For instance, Brandon Ingram faced a similar condition at age 21 and successfully returned after treatment. In the following season, he even won the league’s Most Improved Player award. Another example is Oshae Brissett from Detroit, who also returned to the court after a six-month break.
However, there are less positive stories. Chris Bosh and Mirza Teletovic were forced to retire due to recurring clots. Their cases differ as their issues arose in the legs and lungs, linked to prolonged flights and post-injury rehabilitation. In Wembanyama’s case, the clot is localized in the shoulder, reducing the risk of recurrence.
Unique Abilities May Have Contributed to the Thrombosis
According to sports physician Brian Sutterer, Wembanyama’s height (221 cm) could have been a risk factor. With a height above 190–195 cm, the likelihood of thrombosis nearly doubles. Experts also link the problem to repetitive movements of the shooting hand.
How Will This Affect the San Antonio Spurs?
The Spurs are not contending for a playoff spot this season, so Wembanyama’s absence will not drastically alter the team’s situation. Without their leader, San Antonio will continue competing for a high pick in the 2025 draft, where they might select talented forward Cooper Flagg. On the center position, Bismack Biyombo will step in, and De’Aaron Fox will become the team’s leader.
Photo: Wemby/Instagram
